.Welcome to today's Chutes & Ladders, our summary of considerable leadership hirings, firings and...
.Regeneron is actually back with long-lasting follow-up for its own LAG-3 inhibitor as well as PD-1 ...
.AstraZeneca has actually discussed an early check out the performance of its internal antibody-drug...
.After introducing a phase 3 launch based upon beneficial midstage end results, iTeos as well as GSK...
.The FDA needs to be a lot more available as well as joint to discharge a rise in approvals of uncom...
.It's an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Thera...
.Atea Pharmaceuticals' antiviral has stopped working another COVID-19 test, but the biotech still ho...
.Neurocrine Biosciences' mental illness system pivot has actually stopped working. The biotech was u...
.Sanofi has actually brought in a late entry to the radioligand party, paying one hundred million eu...
.After F2G's 1st effort to get a brand-new lesson of antifungal to market was thwarted by the FDA, t...